1993
DOI: 10.1159/000474583
|View full text |Cite
|
Sign up to set email alerts
|

Protection against Cytotoxic- Induced Testis Damage - Experimental Approaches

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
1
1

Year Published

1995
1995
2015
2015

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(8 citation statements)
references
References 7 publications
0
6
1
1
Order By: Relevance
“…However, hypogonadism does not occur with cisplatin treatment [58,59]. In our experiments, cisplatin caused damage to the testis without significantly changing the circulating levels of testosterone, LH or FSH.…”
Section: Discussioncontrasting
confidence: 47%
“…However, hypogonadism does not occur with cisplatin treatment [58,59]. In our experiments, cisplatin caused damage to the testis without significantly changing the circulating levels of testosterone, LH or FSH.…”
Section: Discussioncontrasting
confidence: 47%
“…Animal studies mostly in rats and mice were carried out in an attempt to confirm the protective effect of GnRH analog administered before cytotoxic insults on spermatogenesis. Several researchers successfully demonstrated the protection of spermatogenesis from procarbazine or cyclophosphamide in the rat model 2–4 . However, other researchers found no substantial protective effects in the mouse or in the rat to the same or other drugs 5–7 .…”
Section: Introductionmentioning
confidence: 99%
“…Meanwhile, cisplatin-based chemotherapy is known to induce azoospermia and impairment of fertility in men [3,5,8]. Animal studies in mice and rats have clearly demonstrated that cisplatin impairs spermatogenic and maturational processes [9,12].…”
mentioning
confidence: 99%